This means Handelsblatt wasn't entirely wrong - the estimated efficacy in over-65s is *6.3 per cent*. But what the story missed is that this figure is completely useless. They just don't have enough data to say anything meaningful. https://t.co/oinzhHTLVG

— Oliver Moody (@olivernmoody) January 28, 2021